Lin BioScience, Inc. (6696.TWO)

TWD 139.5

(4.1%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - -
Cost of Revenue 17.92 Million 11.15 Million 4.39 Million 4.07 Million 4.31 Million
Gross Profit -17.92 Million -11.15 Million -4.39 Million -4.07 Million -4.31 Million
Operating Expenses 1.09 Billion 445.12 Million 338.27 Million 196.99 Million 233.9 Million
Selling, General and Administrative Expenses 242.75 Million 124.25 Million 93.52 Million 51.98 Million 40.56 Million
Research and Development Expenses 854.07 Million 320.87 Million 244.75 Million 145 Million 193.34 Million
Other Expenses - -33.06 Million -152.25 Million 21.95 Million -
Cost and Expenses 1.09 Billion 445.12 Million 338.27 Million 196.99 Million 238.22 Million
Operating Income -1.09 Billion -476.99 Million -490.34 Million -174.53 Million -238.22 Million
Interest Expense 1.21 Million 875 Thousand 71 Thousand 261 Thousand -
Income Tax Expense -29.72 Million -18.43 Million -9.5 Million -22.95 Million -4.77 Million
Earnings before Tax -1.09 Billion -477.87 Million -490.41 Million -174.79 Million -240.03 Million
Net Income -687.19 Million -313.52 Million -434.69 Million -151.84 Million -235.25 Million
Earnings Per Share Basic -9.29 -4.37 -6.23 -2.39 -3.87
Earnings Per Share Diluted -9.29 -4.37 -6.23 -2.39 -3.87
Weighted Average Shares Outstanding 73.98 Million 71.73 Million 69.79 Million 63.53 Million 60.84 Million
Weighted Average Shares Outstanding (Diluted) 73.98 Million 71.73 Million 69.79 Million 63.53 Million 60.84 Million
Gross Margin - - - - -
EBIT Margin - - - - -
Profit Margin - - - - -
EBITDA -1.07 Billion -465.84 Million -485.95 Million -170.46 Million -235.35 Million
Earnings Before Tax Margin - - - - -

Income Statement Charts